Please be really careful and do your due diligence with
SRNE. I've traded it short term before, but would never hold it. Results talk, and the stock has had a run so can't argue there, and the insiders there keep pumping that its a moon-shot, but management is very, very sketchy. Ji has a terrible, terrible rep for playing games with stock options via subsidiaries at shareholder expense. Check under the hood with people in the industry. AGP (pretty shady themselves) did their ATM offering. Lot of BS and risk here. Too much risk to speculate IMO.
Just a taste:
/PRNewswire/ -- Wildcat Capital Management LLC ("Wildcat"), whose clients hold an ownership stake of 6.5% of the common stock of Sorrento Therapeutics, Inc....
www.prnewswire.com
That said, may it run to $200, and may all your cups always be full.